BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AUR107 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AUR107\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05865002-2365@assetmemo.bio
DTSTAMP:20261121T005405Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:AUR107: Phase 1 readout est. (NCT05865002)
DESCRIPTION:AUR107\, phase 1.\nStudy: A Study Evaluating the Safety and Eff
 icacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
 \nEstimated primary completion: January 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/aur107#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT05865002
URL:https://assetmemo.bio/drug/aur107#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
